Braidy, Nady <br/><br/>
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.  [electronic resource] 

 -  Experimental gerontology  04 2020 
 - 110831 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1873-6815 
<br/><br/><label>Standard No.: </label>10.1016/j.exger.2020.110831  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aging--metabolism<br/>Animals<br/>Humans<br/>Inflammation--metabolism<br/>Mice<br/>NAD--metabolism<br/>Neurodegenerative Diseases--metabolism<br/>Niacinamide--analogs & derivatives<br/>Nicotinamide Mononucleotide--metabolism<br/>Oxidative Stress<br/>Pyridinium Compounds<br/>Rats<br/>Risk Assessment